Sabah Shah MD, MBA has Joined the Retina Group of New York Specializing in Uveitis and Vitreoretinal Surgery

Sabah Shah MD, MBA has Joined the Retina Group of New York Specializing in Uveitis and Vitreoretinal Surgery

Hicksville, NY (PRWEB) December 05, 2016

Sabah Shah MD, MBA has joined the Retina Group of New York (RGONY) specializing in uveitis and vitreoretinal surgery. The Retina Group of New York was founded by James M. Maisel, MD and has been providing tertiary medical and surgical retinal care on Long Island for over 30 years.

Dr. Shah has always followed a legacy of surpassing expectations amongst her peers. Growing up in a family of doctors, Dr. Shah emulated the role of a physician as a medical healer. At the age of 17, she was only one of 18 high school students in the entire country accepted directly into medical school from high school. She was granted direct admission into the 8-year Leadership in Medicine program at Union University and Albany Medical College. She excelled academically during her studies, attaining a dual Bachelor's degree in Biology and Spanish, an MBA in healthcare administration, and lastly her medical degree from Albany Medical College.

After graduating at the top of her class from Albany Medical College, Dr. Shah completed her internship at New York Presbyterian-Queens of Weill Cornell Medical Center. She then completed a prestigious three-year ophthalmology residency at New York University and Manhattan Eye, Ear & Throat Hospital, training under world-renowned retina specialists. Upon completing her residency training, Dr. Shah returned to upstate New York to complete a two-year combined fellowship in vitreoretinal surgery and uveitis. Dr. Shah was appointed as Assistant Professor of Ophthalmology at Albany Medical College and was awarded the Resident Teaching Award for her excellence in instructing surgical and medical techniques to residents.

During her training, Dr. Shah has published numerous papers on anti-VEGF medications including Avastin, Lucentis and Eylea, and procedures that are currently used by retina specialists such as retinal detachment repair and macular pucker surgery. She has participated in ongoing clinical trials involving pathology for macular degeneration and uveitis. Furthermore, Dr. Shah has presented her research, received research scholarships and awards, and has given lectures at the national level to hundreds of physicians across the country.

Dr. Maisel states, "It is a privilege to have Dr. Shah join RGONY as the only ophthalmologist on Long Island to be fellowship trained in both retina and uveitis. Dr. Shah has extensive experience in some of the most sophisticated and groundbreaking medical and surgical techniques and we look forward to having her bring that expertise to RGONY and our patients. She has performed thousands of eye injections, retina lasers, and surgery for retinal detachment, macular puckers, and vitrectomies. Her comprehensive training, coupled with her amiable personality makes her a valuable addition to our specialized tertiary retina and uveitis practice."

Dr. Shah adds, "It is an honor to be a part of the medical and surgical community specializing in the management of retina and uveitis patients in Long Island. Having grown up in Long Island, I am excited to come back to serve my community. I enjoy meeting new patients and my passion in life is my career which enables me to restore vision and independence."

About the Retina Group of New York
The Retina Group of New York has provided tertiary retinal and uveitis care to patients in Nassau and Suffolk Counties since 1986 at its offices in Hicksville and Hauppauge. Both locations are fully equipped with in-office laser capabilities, cutting edge diagnostic imaging, and integrated electronic records. The group holds staff privileges at seven area hospitals and teaching appointments at the Hofstra North Shore-LIJ School of Medicine, North Shore University Hospital, and Nassau University Medical Center. The practice is limited to medical and surgical retinal and uveitis problems. These commonly include diabetic retinopathy, macular degeneration, retinal vein occlusion, retinal detachment, macula pucker, macula hole, cataract surgery complications, uveitis, retinal degenerations, Plaquenil toxicity and second opinions.

The group, led by CEO and founder James M. Maisel, MD, consists of Board Certified Ophthalmologists who have additional Fellowship Training from top institutions including New York Presbyterian-Cornell Medical Center, University of Pittsburgh and Albany Medical Center. They are complemented by specialized ophthalmic certified RNs, Health Information Management Specialists and Ophthalmic Technicians.The Retina Group of New York utilizes state-of-the-art diagnostic equipment and offers in-office laser treatment for diabetic retinopathy and treatment for macular degeneration and diabetic macular edema with intravitreal medications including Eylea®, Lucentis®, Ozurdex® and Iluvien®. Keeping abreast of the latest treatments, members of the group serve on the medical advisory boards of Regeneron, Allergan, Genetech and Alimera, and lecture across the U.S. to other retina specialists about macular degeneration and diabetic retinopathy. More information is available online at http://www.rgony.com.

Retina Group of New York Offices
400 S. Oyster Bay Road
Hicksville, NY 11801
516-939-6100

1455 Veterans Memorial Highway
Hauppauge, NY 11788
631-273-1818

For the original version on PRWeb visit: http://www.prweb.com/releases/retina/uveitis/prweb13884095.htm